Cosmo N.V. (C43.F)
Cosmo N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
66.20+0.02%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+7.6%
The outlook
Cosmo N.V. currently reads as bearish based on below its 50- & 200-day averages, 10% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range10% of the way from its 52-week low to high
Market cap
$1.14B
52-wk high
141.00
52-wk low
57.50
50-day avg
75.01
200-day avg
93.80
Trailing P/E
—